Cargando…

Protective effect of Idelalisib on carbon tetrachloride‐induced liver fibrosis via microRNA‐124‐3P/phosphatidylinositol‐3‐hydroxykinase signalling pathway

Liver fibrosis is the repair process of abnormal connective tissue hyperplasia after liver damage caused by different causes. Inhibition of PI3K/Akt signalling pathway can reduce the deposition of extracellular matrix, inhibit the proliferation of hepatic stellate cells (HSCs), and promote its apopt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiaohe, Li, Hailong, Zhang, Shanshan, Zhang, Ruotong, Li, Jinhe, Wei, Yiying, Yang, Cheng, Zhang, Fubo, Zhou, Honggang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650042/ https://www.ncbi.nlm.nih.gov/pubmed/34747105 http://dx.doi.org/10.1111/jcmm.17039

Ejemplares similares

Byakangelicin protects against carbon tetrachloride–induced liver injury and fibrosis in mice
por: Li, Xiaohe, et al.
Publicado: (2020)

FOXO3 regulates Smad3 and Smad7 through SPON1 circular RNA to inhibit idiopathic pulmonary fibrosis
por: Li, Hailong, et al.
Publicado: (2023)

Protective Effect of Arbidol Against Pulmonary Fibrosis and Sepsis in Mice
por: Li, Hailong, et al.
Publicado: (2021)

Idelalisib: The First-in-Class Phosphatidylinositol 3-Kinase Inhibitor for Relapsed CLL, SLL, and Indolent NHL
por: Forcello, Nicholas, et al.
Publicado: (2014)

Protective effects of Liuweiwuling tablets on carbon tetrachloride-induced hepatic fibrosis in rats
por: Liu, Huimin, et al.
Publicado: (2018)

Oridonin ameliorates carbon tetrachloride‐induced liver fibrosis in mice through inhibition of the NLRP3 inflammasome
por: Liu, Dong, et al.
Publicado: (2020)

Idelalisib for the Treatment of Chronic Lymphocytic Leukemia
por: Khan, Maliha, et al.
Publicado: (2014)

Idelalisib: a rare cause of enterocolitis
por: Balagoni, Harika, et al.
Publicado: (2016)

Idelalisib induces PUMA-dependent apoptosis in colon cancer cells
por: Yang, Shida, et al.
Publicado: (2016)

Structural, Biochemical, and Biophysical Characterization of Idelalisib Binding to Phosphoinositide 3-Kinase δ
por: Somoza, John R., et al.
Publicado: (2015)

Protective Effects of Amarogentin against Carbon Tetrachloride-Induced Liver Fibrosis in Mice
por: Zhang, Ya, et al.
Publicado: (2017)

Palmitic acid declines glucose uptake in HepG2 cells via modulating phosphoglucomutase 1 to repress phosphatidylinositol 3 kinase/protein kinase B and JNK pathways via inducing microRNA-124-3p
por: ZHANG, LingHui, et al.
Publicado: (2022)

The PI3Kδ inhibitor idelalisib impairs the function of human dendritic cells
por: Braun, Christiane, et al.
Publicado: (2021)

Dabrafenib, idelalisib and nintedanib act as significant allosteric modulator for dengue NS3 protease
por: Uday, R. V. Sriram, et al.
Publicado: (2021)

Contribution and Mobilization of Mesenchymal Stem Cells in a mouse model of carbon tetrachloride-induced liver fibrosis
por: Liu, Yan, et al.
Publicado: (2015)

Chronic restraint stress reduces carbon tetrachloride-induced liver fibrosis
por: LI, MENG, et al.
Publicado: (2016)

The PI3Kδ Inhibitor Idelalisib Diminishes Platelet Function and Shows Antithrombotic Potential
por: Barrachina, María N., et al.
Publicado: (2021)

Crystal structure of idelalisib tert-butanol monosolvate dihydrate
por: Nerdinger, Sven, et al.
Publicado: (2019)

Carvedilol attenuates carbon tetrachloride-induced liver fibrosis and hepatic sinusoidal capillarization in mice
por: Wu, Ying, et al.
Publicado: (2019)

Phillygenin Attenuates Carbon Tetrachloride-Induced Liver Fibrosis via Modulating Inflammation and Gut Microbiota
por: Wang, Cheng, et al.
Publicado: (2021)

Efficacy and Safety of Tirabrutinib and Idelalisib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia
por: Kutsch, Nadine, et al.
Publicado: (2022)

Final Results of a Randomized, Phase III Study of Rituximab With or Without Idelalisib Followed by Open-Label Idelalisib in Patients With Relapsed Chronic Lymphocytic Leukemia
por: Sharman, Jeff P., et al.
Publicado: (2019)

Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia
por: Eldfors, S, et al.
Publicado: (2017)

The PI3Kδ Inhibitor Idelalisib Inhibits Homing in an in Vitro and in Vivo Model of B ALL
por: Adam, Etai, et al.
Publicado: (2017)

Idelalisib promotes Bim-dependent apoptosis through AKT/FoxO3a in hepatocellular carcinoma
por: Yue, Dan, et al.
Publicado: (2018)

Management of adverse events associated with idelalisib treatment: expert panel opinion
por: Coutré, Steven E., et al.
Publicado: (2015)

Enhancing Therapeutic Efficacy of Double Negative T Cells against Acute Myeloid Leukemia Using Idelalisib
por: Kang, Hyeonjeong, et al.
Publicado: (2021)

Sappanone A Alleviates the Severity of Carbon Tetrachloride-Induced Liver Fibrosis in Mice
por: Qi, Jing, et al.
Publicado: (2023)

Lycopene improves autophagy and attenuates carbon tetrachloride-induced hepatic fibrosis in rats
por: Li, Wei, et al.
Publicado: (2023)

Duvelisib attenuates bleomycin‐induced pulmonary fibrosis via inhibiting the PI3K/Akt/mTOR signalling pathway
por: Li, Xiaohe, et al.
Publicado: (2023)

Idelalisib impairs TREM-1 mediated neutrophil inflammatory responses
por: Alflen, Astrid, et al.
Publicado: (2018)

Rapid and complete response to idelalisib in a case of Richter syndrome
por: Bagacean, Cristina, et al.
Publicado: (2019)

Idelalisib may have the potential to increase radiotherapy side effects
por: Gryc, Thomas, et al.
Publicado: (2017)

Transcriptional Modulation by Idelalisib Synergizes with Bendamustine in Chronic Lymphocytic Leukemia
por: Kost, Sara E. F., et al.
Publicado: (2019)

A novel strategy for the manufacture of idelalisib: controlling the formation of an enantiomer
por: Mekala, Nagaraju, et al.
Publicado: (2018)

An unusual case of Idelalisib‐related pneumonitis with severe respiratory failure
por: Sousa, Domingos, et al.
Publicado: (2020)

Fedratinib Attenuates Bleomycin-Induced Pulmonary Fibrosis via the JAK2/STAT3 and TGF-β1 Signaling Pathway
por: Ruan, Hao, et al.
Publicado: (2021)

Palmitoylethanolamide Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis in Rats
por: Ohara, Masatsugu, et al.
Publicado: (2018)

Cadherin-11 contributes to liver fibrosis induced by carbon tetrachloride
por: Pedroza, Mesias, et al.
Publicado: (2019)

The Genetic Architecture of Carbon Tetrachloride-Induced Liver Fibrosis in Mice
por: Tuominen, Iina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i3no4mfb3pvjk75tnvvd35s084